[go: up one dir, main page]

AU2003286251A1 - New bicyclic angiotensin ii agonists - Google Patents

New bicyclic angiotensin ii agonists

Info

Publication number
AU2003286251A1
AU2003286251A1 AU2003286251A AU2003286251A AU2003286251A1 AU 2003286251 A1 AU2003286251 A1 AU 2003286251A1 AU 2003286251 A AU2003286251 A AU 2003286251A AU 2003286251 A AU2003286251 A AU 2003286251A AU 2003286251 A1 AU2003286251 A1 AU 2003286251A1
Authority
AU
Australia
Prior art keywords
angiotensin
agonists
new bicyclic
bicyclic
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003286251A
Inventor
Mathias Alterman
Anders Hallberg
Murugaiah Andappan Murugaiah Subbaiah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicore Pharma AB
Original Assignee
Vicore Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicore Pharma AB filed Critical Vicore Pharma AB
Publication of AU2003286251A1 publication Critical patent/AU2003286251A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003286251A 2002-11-21 2003-11-19 New bicyclic angiotensin ii agonists Abandoned AU2003286251A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42793802P 2002-11-21 2002-11-21
US60/427,938 2002-11-21
PCT/GB2003/005038 WO2004046128A1 (en) 2002-11-21 2003-11-19 New bicyclic angiotensin ii agonists

Publications (1)

Publication Number Publication Date
AU2003286251A1 true AU2003286251A1 (en) 2004-06-15

Family

ID=32326617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003286251A Abandoned AU2003286251A1 (en) 2002-11-21 2003-11-19 New bicyclic angiotensin ii agonists

Country Status (2)

Country Link
AU (1) AU2003286251A1 (en)
WO (1) WO2004046128A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5179349B2 (en) * 2005-04-12 2013-04-10 ヴィコール・ファルマ・アーベー Novel bicyclic angiotensin II agonist
US8067418B2 (en) 2005-04-12 2011-11-29 Vicore Pharma Ab Tricyclic angiotensin II agonists
ES2395194T3 (en) 2005-04-12 2013-02-11 Vicore Pharma Ab New tricyclic agonists of angiotensin II
CA2690226C (en) 2007-06-20 2012-07-24 Mitsubishi Tanabe Pharma Corporation Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
JP5869222B2 (en) 2008-01-04 2016-02-24 インテリカイン， エルエルシー Specific chemical entities, compositions and methods
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
SG10201600179RA (en) 2011-01-10 2016-02-26 Infinity Pharmaceuticals Inc Processes for preparing isoquinolinones and solid forms of isoquinolinones
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
HUE040126T2 (en) 2012-11-01 2019-02-28 Infinity Pharmaceuticals Inc Treatment of cancers using modulators of PI3 kinase isoform
WO2015152393A1 (en) 2014-04-03 2015-10-08 国立研究開発法人国立循環器病研究センター Medicine for suppressing malignant tumor metastasis
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
UA125216C2 (en) 2016-06-24 2022-02-02 Інфініті Фармасьютікалз, Інк. COMBINED THERAPY
EP4007592A1 (en) 2019-08-02 2022-06-08 LanthioPep B.V. Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10112041A1 (en) * 2001-03-14 2002-09-26 Aventis Pharma Gmbh p-Thienylbenzylamides as agonists of angiotensin (1-7) receptors, processes for their preparation, their use and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2004046128A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003302106A1 (en) New tricyclic angiotensin ii agonists
AU2003302027A1 (en) New tricyclic angiotensin ii agonists
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003257094A1 (en) Substituted benzimidazole compounds
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2003268304A1 (en) Toolholder
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003270297A1 (en) Toolholder
AU2003219291A1 (en) Bicyclic compounds useful as angiotensin ii agonists
AU2003287406A1 (en) Digital-rights management
AU2003286251A1 (en) New bicyclic angiotensin ii agonists
AU2003299276A1 (en) Composite shaped block
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003248356A1 (en) Beta3-adrenergic receptor agonists
AU2003295427A1 (en) Flaviviris fusion inhibitors
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003206730A1 (en) Fitting
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2003249537A1 (en) Defect area management
AU2003270351A1 (en) Anesthetic-state determining
AU2002952559A0 (en) New use
AU2003298683A1 (en) Cable-testing adapter
AU2003264722A1 (en) Methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase